Cancer Treatment Current Events | Page 25

Cancer Treatment Current Events, Cancer Treatment News Articles.
Sort By: Most Viewed | Most Recent
Page 25 of 25 | 1000 Results
Beta-blockers help reduce metastasis and improve survival in breast cancer patients
Treatment with beta-blockers can help reduce the spread of cancer, says the first study in the world to have investigated their effect in breast cancer patients. Patients treated with beta-blockers showed a significant reduction in metastasis and better survival. The use of beta-blockers appears to slow down tumor growth and could also be used to target those patients who have an increased risk of developing secondary cancers. The study will be presented at the European Breast Cancer Conference on Friday, March 26. (2010-03-26)

News brief: Informative method to identify biomarkers for guiding therapy decisions
A randomized biomarker-stratified design, which uses the biomarker to guide analysis but not treatment assignment, provides a rigorous assessment of the utility of a potential biomarker for guiding therapy, according to a commentary published online Jan. 14 in the Journal of the National Cancer Institute. (2010-01-14)

Zika viruses show potential as treatment for high-risk childhood cancer
Zika virus may hold potential as a cancer treatment for neuroblastoma, a rare-but-deadly childhood cancer, according to early findings from basic research published today in PLOS ONE. (2018-07-25)

HER2 levels may aid in treatment selection for metastatic breast cancer
Findings published in the Dec. 1, 2008, issue of Clinical Cancer Research, a journal of the American Association for Cancer Research, show lapatinib benefits women with HER2-positive breast cancer, while women with HER2-negative breast cancer or those who express EGRF alone derive no incremental benefit. In addition, a misclassification of metastatic breast cancer patients by as much as 10 percent prevents some people from receiving optimal therapy. (2008-12-02)

More aggressive treatment not necessary for men with a family history of prostate cancer
There are three major factors that are used to evaluate the extent and aggressiveness of prostate cancer, help make treatment decisions, and estimate prognosis: the prostate specific antigen level, Gleason score from the biopsy, and the digital rectal exam findings. However, men with a family history of prostate cancer have often been feared to have a more aggressive form of the disease not otherwise represented by these three factors and therefore are sometimes urged to undergo more aggressive treatment. (2011-10-05)

Fox Chase Cancer Center ovarian cancer prevention trial uses vitamin A-related medicine
Fox Chase Cancer Center is offering a new prevention study for women at increased risk of ovarian cancer. Women who have decided to have their ovaries removed may be eligible to take part in this clinical trial of cancer chemoprevention-the use of natural or man-made agents to prevent cancer. (1999-12-16)

Patients receiving radioactive seed implant therapy have improved quality of life post-treatment
Researchers at Mount Sinai School of Medicine have found that prostate cancer patients receiving radioactive seed implant therapy (brachytherapy) have preserved rectal, urinary and sexual quality of life four years or more after treatment, according to data presented at the American Urological Association (AUA)'s Annual Meeting in San Francisco, CA. (2004-05-10)

Rural women more likely to be diagnosed with most serious form of breast cancer
An MU researcher has found that rural women are more likely than women living in cities to be diagnosed with late-stage breast cancer, the most severe form of the disease. (2011-10-24)

1 in 5 early-stage breast cancer patients may not follow hormonal therapy plan
Postmenopausal women with early-stage, hormone-sensitive breast cancer have a lower risk of disease recurrence when their treatment includes a new class of hormone therapy drugs, yet one out five women prescribed the drugs may not take them regularly. (2006-12-16)

Drug combination increases susceptibility to chemotherapy in cases of severe neuroblastoma
Researchers at the University of Gothenburg now suggest a possible cure for children with hard-to-treat forms of neuroblastoma using a new combination of drugs. In a new study in the journal Cancer Research, they describe how a two small molecule-based drug combination likely inhibit the tumor's growth. (2021-01-07)

Patients with advanced cancer willing to accept riskier chemotherapy
People with advanced cancer are more willing than healthy people or doctors to consider a toxic chemotherapy regimen even if it offers only a minimal chance of slowing their cancer, according to a new study. (2001-07-06)

Cancer cells in blood can identify risk of recurrence in breast cancer
Cancer cells circulating in the blood are known to be associated with a bad prognosis in metastatic breast cancer. Now, for the first time, scientists have shown they can also detect the cells before and after chemotherapy and hence may be able to identify in the future those patients likely to have a recurrence after treatment. (2007-09-24)

New target identified to stop the spread of breast cancer
A new potential target to slow breast cancer tumor progression and metastasis has been identified by a team of researchers led by Dr. Richard Kremer from the Research Institute of the McGill University Health Center. (2011-11-10)

Significant benefits in non-small-cell lung cancer from customizing erlotinib treatment
Lung cancer patients whose tumors carry specific genetic mutations can achieve significantly longer survival when treated with targeted therapies such as erlotinib, Spanish researchers report. (2008-09-14)

Cancer conference unveils new alternative therapies, research
Comprehensive Cancer Care is nation's only conference exploring how alternative and traditional therapies work together. Sponsored by NCI and NCCAM, conference includes sessions on innovative treatments: nutritional therapy for pancreatic cancer, homeopathic treatment for gastric and esophageal cancer, novel approaches to breast and prostate cancer, and new Chinese herbal therapies. (2000-05-30)

Treatment disparities drive worse outcomes for pediatric Black, Hispanic brain cancer pts
Of 1,881 patients under age 19 diagnosed with cancers of the brain and central nervous system between 2000 and 2015, 52 percent of White patients lived five years from diagnosis, whereas only 44 percent of African American patients and 45 percent of Hispanic patients reached a similar milestone. (2020-03-12)

How much is life worth? The $440 billion question
The decision to use expensive cancer therapies that typically produce only a relatively short extension of survival is a serious ethical dilemma in the US that needs to be addressed by the oncology community, according to a commentary published online June 29 in the Journal of the National Cancer Institute. (2009-06-29)

Survey finds significant racial differences in lung cancer beliefs
A new survey finds that while both whites and African-Americans know and think little about lung cancer, African-Americans are more likely to hold beliefs and perceptions about the disease that could interfere with prevention and treatment. (2010-02-22)

Lung cancer signatures in blood samples may aid in early detection
Now, a new study published by Cell Press in the Sept. 13 issue of the journal Cancer Cell identifies protein signatures in mouse blood samples that reflect lung cancer biology in humans. The research may lead to better monitoring of tumor progression as well as blood based early detection strategies for human lung cancer that could have a substantial impact on disease prognosis. (2011-09-12)

Specialists make breakthrough in the treatment of anal cancer
Specialists at The Christie and The University of Manchester have made a breakthrough which could potentially improve detection and treatment of anal cancer, as well as have wider implications for other cancers. (2017-08-16)

Many advanced breast cancer patients do not receive recommended treatment
Radiation after a mastectomy for women with advanced breast cancer saves lives, but almost half of these patients do not receive it. That is the conclusion of a new study published early online in Cancer. (2011-06-27)

Popular chemotherapy drug may be less effective in overweight and obese women
Breast cancer patients who are overweight or obese might benefit less from treatment with docetaxel, a common chemotherapy drug, than lean patients, a new study finds. (2020-07-02)

Racial disparities seen in male breast cancer survival
A new study shows that among men treated for breast cancer, African-American men are more likely to die of the disease compared with white men. The results of the study are being published online March 16 in the Journal of Clinical Oncology. (2007-03-16)

Chemo-resistant tumors targeted by BU School of Medicine researcher
Rachel Flynn, Ph.D., assistant professor of pharmacology and medicine at Boston University School of Medicine, is the recipient of an Elsa U. Pardee award for approximately $148,000 for 'Targeting the Alternative Lengthening of Telomeres (ALT) Pathway in cancer.' This pathway is frequently reactivated in aggressive cancers such as osteosarcoma and glioblastoma, which are often resistant to standard chemotherapy. (2015-11-02)

Technology that could double the effectiveness of cancer drugs studied at Yale
To identify the best treatment for recurrent ovarian cancer, researchers at Yale School of Medicine are studying a technology called the Yale apoptosis assay in combination with another technology, which could double the response rate to existing drugs. (2005-01-20)

Combination therapy may enhance gemcitabine activity
Oncologists who treat patients with pancreatic cancer may be one step closer to understanding why gemcitabine, the only currently available treatment, works in some cases but not in others, according to a paper in Cancer Discovery. (2012-02-28)

Nottingham scientist investigates breast cancer cell survival
University of Nottingham scientist Dr Stewart Martin has received a project grant from Breast Cancer Campaign, the only charity that specialises in funding independent breast cancer research throughout the UK. The three year grant, worth over £140,000, forms part of over £4.2 million invested in research by Campaign in the last year. (2007-08-23)

ER/PR negative tumors associated with insurance status
African-American women are at a higher risk for ER/PR negative breast cancer. A new study, to be presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research, found that race, socioeconomic characteristics and other tumor characteristics are all important predictors of having ER/PR negative breast cancer. (2008-11-18)

False negative tests in breast cancer may lead to wrong drug choice
A team of Yale Cancer Center researchers has confirmed that between 10-20 percent of breast cancers classified as estrogen receptor negative are really positive. Understanding when and why breast cancers may be misclassified has important implications for treatment and outcomes for women diagnosed with breast cancer. Its findings are published online in the June 28 Journal of Clinical Oncology. (2011-06-27)

Special yoga classes aimed at breast cancer survivors improves recovery
A University of Alberta researcher examined how a specialized Iyengar yoga program for breast cancer survivors makes a difference in their recovery. (2010-08-17)

Virus a potential future cancer medicine
In a new project, researchers from LIFE -- the Faculty of Life Sciences at the University of Copenhagen -- document that the vesicular stomatitis virus plays a previously unknown dual role in the prevention of a number of cancers. (2011-09-16)

Gene expression pattern predicts response in advanced bowel cancer
Research has shown for the first time that identifying patterns of gene expression can be used to predict response to treatment in patients with advanced metastatic colorectal cancer. (2008-10-22)

Endometriosis increases the risk of certain cancers
Doctors in Sweden have shown for the first time that although endometriosis is associated with an increased risk of various cancers, this risk does not depend on the number of times women with the condition have given birth. (2007-07-02)

Report shows benefits of combining vitamin D with Taxotere, for advanced prostate cancer
The combination of vitamin D and chemotherapy agent Taxotere has shown to be effective in treating advanced prostate cancer. This study was published in the Jan. 1 issue of the Journal of Clinical Oncology. (2003-01-02)

Will lung cancer recur? A genetic test may provide the answer
The goal of developing reliable genetic tests to guide lung cancer treatment has taken a step forward. Researchers at Columbia University recently evaluated the ability of five high-risk genetic profiles, or signatures, to predict the likelihood that cancer would recur in patients whose nonsmall cell lung cancer was caught early and surgically removed. They will present their findings at the American Thoracic Society's 2008 International Conference in Toronto on Tuesday, May 20. (2008-05-19)

Wide variations in appropriateness of rectal cancer surgery across England
A substantial proportion of rectal cancer patients are receiving inappropriate surgical care, because of wide variations in practice across England, reveals research published ahead of print in the journal Gut. (2008-06-04)

Whole body PET proves accurate in detecting breast cancer spread
Whole body 18FDG-PET is a more accurate test than CT for locating cancer spread in breast cancer patients, a new study shows. (2003-05-06)

Promising use of nanodiamonds in delivering cancer drug to kill cancer stem cells
A study led by the National University of Singapore found that attaching chemotherapy drug Epirubicin to nanodiamonds effectively eliminates chemo-resistant cancer stem cells. (2015-01-25)

Experimental insulin-like growth factor receptor inhibitor reduced pancreatic cancer growth
Researchers at Amgen are testing a fully human monoclonal antibody that inhibits the activity of insulin-like growth factors (IGF-1 and IGF-2) and appears to reduce pancreatic cancer cells in early testing, according to a report in Molecular Cancer Therapeutics, a journal of the American Association for Cancer Research. (2009-04-14)

Metformin may lower cancer risk in people with Type 2 diabetes
A commonly prescribed diabetes drug, metformin, reduces the overall cancer risk in people with Type 2 diabetes, a large systematic review study finds. The results will be presented Monday at the Endocrine Society's 94th Annual Meeting in Houston. (2012-06-25)

Page 25 of 25 | 1000 Results
   First   Previous   Next      Last is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to